stars 1 stars 2 stars 3

Morflora develops a bio-based generic and non-transgenic trait introduction solution into plants and seeds, to protect them from a wide variety of diseases, as well as introduce new desired traits for plant and seed enhancement. The company targets the seed treatment market, and non-seed and plant treatment markets with plant protection and enhancement solutions in order to reduce dependency on chemical treatments in plants, and increase global crop yield. So far experiments were conducted in vegetables, vines and trees, and response to a number of pathogens, have yielded promising results. The next step is to explore TraitUP’s™ potential as a plant enhancement solution. Morflora’s combination of independent development efforts, the intellectual property it holds, and the knowledge and expertise of its scientists allows for a unique offering and a technological breakthrough which can significantly affect a wide variety of agricultural markets. TraitUP™ is a patent-pending technology developed at the Hebrew University by Prof. Haim Rabinowitch and Prof. Ilan Sela. The patents are co-owned by Morflora and Yissum and under exclusive licensing agreement with Yissum (Yissum is the technology transfer arm of the Hebrew University of Jerusalem). Established in 2008, the company is supported by private investors.

Morflora Questions

The Morflora annual revenue was $5.4 million in 2026.

3 people are employed at Morflora.

The NAICS codes for Morflora are [11, 111].

The SIC codes for Morflora are [28, 283, 80].

Top Morflora Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users